(a) Phenylketonuria.
(b) Homozygous sickle cell disease.
(c) Hypothyroidism.
(d) Branched-chain ketonuria.
(e) Galactosemia.
(f) Homocystinuria.
(g) Critical congenital heart defects through pulse oximetry
screening.
(h) With regard to any newborn infant who is identified as, or
suspected of, having a hearing impairment as a result of a screening
conducted pursuant to section twenty-five hundred-g of this title, a
urine polymerase chain reaction (PCR) test for cytomegalovirus, unless
the parent of the infant objects thereto; provided that if the
commissioner determines that another test for cytomegalovirus is
diagnostically equivalent to or better than the urine polymerase chain
reaction test, the commissioner may, by regulation under this section,
allow or require the use of that other test.
(i) Adrenoleukodystrophy.
(j) Glucose-6-phosphate dehydrogenase deficiency using a quantitative
enzymatic test or other diagnostic test in cases where: the newborn
infant presents with hemolytic anemia, hemolytic jaundice, or
early-onset increasing neonatal jaundice, that is, jaundice (bilirubin
level greater than fortieth percentile for age in hours) persisting
beyond the day of birth through the week after birth; the newborn infant
has been admitted to the hospital for jaundice following birth; or the
biological parent of the newborn infant indicates a family, racial, or
ethnic risk of glucose-6-phosphate dehydrogenase deficiency, including
having significant African, Asian, Mediterranean, or Middle Eastern
ancestry.
2. Testing, the recording of the results of such tests, tracking,
follow-up reviews and educational activities shall be performed at such
times and in such manner as may be prescribed by the commissioner. The
commissioner shall promulgate regulations setting forth the manner in
which information describing the purposes of the requirements of this
section shall be disseminated to parents or a guardian of the infant
tested.
3. The provisions of this section shall not apply in the case of any
infant or child whose parent or guardian is a member of a recognized
religious organization whose teachings and tenets are contrary to the
testing herein required and who notifies the person charged with having
such test administered of his objection thereto.
Structure New York Laws
Article 25 - Maternal and Child Health
2500 - Maternal and Child Health; Duties of Commissioner.
2500-A - Test for Phenylketonuria and Other Diseases and Conditions.
2500-B - Sudden Infant Death Syndrome.
2500-C - Special Programs With Respect to Diethylstilbestrol.
2500-D - New York State Poison Control Network.
2500-E - Pregnant Women, Blood Test for Hepatitis B; Follow-Up Care.
2500-F - Human Immunodeficiency Virus; Testing of Newborns.
2500-F-1 - Special Program for HIV Services for Women and Children, Including Adolescents.
2500-G - Newborn Infant Hearing Screening.
2500-H - Statewide Perinatal Data System.
2500-H*2 - Anaphylactic Policy for School Districts and Child Care Providers.
2500-I - Child Food Choking Prevention.
2500-J - Autism Spectrum Disorders; Screening of Children.
2500-L - Pregnant People, Blood Test for Hepatitis C Virus (Hcv); Follow-Up Care.
2501 - Health and Welfare Services to All Children; Duty of Local Boards.
2502 - Report of Certain Conditions.
2503 - Drug Information to Be Furnished Expectant Mothers.
2504-A - Hepatitis B Immunization of a Minor.
2504-B - Information Concerning Pelvic Exams.
2505 - Human Breast Milk; Collection, Storage and Distribution; General Powers of the Commissioner.
2505-A - Rights of Breastfeeding Mothers.
2505-B - Lactation Accommodations in Airports.
2506 - Obstetric and Pediatric Practitioner Incentive Demonstration Program.
2507 - Special Supplemental Nutrition Program for Women, Infants and Children; Specialty Formula.
2508 - Newborn Health and Safe Sleep Study.
2509 - Maternal Mortality Review Board.
2509-A - Corded Window Blind Leaflet.
2509-C - Availability of Adverse Childhood Experiences Services.